EBS: Operation Warp Speed Timeline
Emergent BioSolutions is well known for owning the rights to the pioneering technology behind the Narcan nasal spray. Naloxone has been around for years as an injectable for opioid overdoses which required expertise to administer. Narcan spray eliminated the expertise requirement.
Recently, EBS entered into several large contracts with giant pharma and will serve as manufacturers of leading COVID-19 vaccine candidates. They are working with Department of Defense; Department of Health and Human Services; Johnson & Johnson; and AstraZeneca.
The deal with JNJ starts in 2021 and lasts 5 years.
As more and more vaccines pass trials and get approved, biotech companies will need a manufacturer to sign with and I believe that EBS will be the go-to because of their size and ability to scale.
Currently waiting for a buy signal.
Recently, EBS entered into several large contracts with giant pharma and will serve as manufacturers of leading COVID-19 vaccine candidates. They are working with Department of Defense; Department of Health and Human Services; Johnson & Johnson; and AstraZeneca.
The deal with JNJ starts in 2021 and lasts 5 years.
As more and more vaccines pass trials and get approved, biotech companies will need a manufacturer to sign with and I believe that EBS will be the go-to because of their size and ability to scale.
Currently waiting for a buy signal.
Comment:
Did some tweaks to the script. The pattern that appears repeat is: the dominant trend will reverse once price enters the colored areas.
Additionally, the holding period for this stock range from 2 weeks to 1 month.
Did some tweaks to the script. The pattern that appears repeat is: the dominant trend will reverse once price enters the colored areas.
Additionally, the holding period for this stock range from 2 weeks to 1 month.
Buy signal is in.